DNA promoter methylation in urothelial cancer: a feature of the invasive phenotype and a novel therapeutic target

DNA promoter methylation in urothelial cancer: a feature of the invasive phenotype and a novel therapeutic target

Bibliographic Details
Main Authors:	Catto, J, Dhawan, D, Meuth, M, Cussenot, O, Azzouzi, A, Hamdy, F
Format:	Journal article
Published:	2006

Similar Items

Epigenetic changes in urothelial cancer: A feature of the invasive phenotype and a novel therapeutic target
by: Catto, J, et al.
Published: (2006)

Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma.
by: Dhawan, D, et al.
Published: (2006)

Aberrant promoter methylation in pre-malignant and invasive tumours of the urinary bladder
by: Yates, D, et al.
Published: (2005)

Behavior of urothelial carcinoma with respect to anatomical location.
by: Catto, J, et al.
Published: (2007)

FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
by: van Oers, J, et al.
Published: (2009)

Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearance.
by: Catto, J, et al.
Published: (2006)

A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis.
by: Rouprêt, M, et al.
Published: (2008)

Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.
by: Rouprêt, M, et al.
Published: (2005)

Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.
by: Catto, J, et al.
Published: (2005)

A comparative analysis of the behaviour of urothelial carcinoma with respect to anatomical location
by: Catto, J, et al.
Published: (2007)

Clinically localised prostate cancer is microsatellite stable.
by: Azzouzi, A, et al.
Published: (2007)

Mutation of the FGFR3 oncogene is an independent and favorable prognostic factor for tumor-specific survival in patients with urothelial carcinoma of the upper urinary tract
by: Burger, M, et al.
Published: (2006)

[Mutation of the FGFR3 oncogene is an independent and favorable prognostic factor for tumor-specific survival in patients with urothelial carcinoma of the upper urinary tract].
by: Burger, M, et al.
Published: (2006)

The role of genetic instability in the pathogenesis and progression of urothelial carcinoma
by: Catto, J, et al.
Published: (2005)

Development of a prognostic marker panel in bladder cancer using aberrant promoter methylation
by: Catto, J, et al.
Published: (2007)

Comparing gene promoter methylation frequencies in urine from patients with bladder cancer with urine from non-cancerous young and elderly control patients
by: Yates, DR, et al.
Published: (2005)

Integrated epigenome profiling of repressive histone modifications, DNA methylation and gene expression in normal and malignant urothelial cells.
by: Ewa Dudziec, et al.
Published: (2012-01-01)

Distinct patterns of microsatellite instability are seen in tumours of the urinary tract.
by: Catto, J, et al.
Published: (2003)

Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.
by: Rehman, I, et al.
Published: (2005)

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression.
by: Rouprêt, M, et al.
Published: (2008)

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression
by: Roupret, M, et al.
Published: (2008)

Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls.
by: Yates, DR, et al.
Published: (2006)

Compared performance of microsatellite and methylation urinalysis in predicting recurrence in transitional cell carcinoma and definition of a diagnostic panel of markers by bayesian network analysis
by: Roupret, M, et al.
Published: (2007)

The miRNome of canine invasive urothelial carcinoma
by: Mara S. Varvil, et al.
Published: (2022-08-01)

Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study.
by: Rehman, I, et al.
Published: (2004)

In-Vitro Identification and In-Vivo Confirmation of DNA Methylation Biomarkers for Urothelial Cancer
by: Christina U. Köhler, et al.
Published: (2020-07-01)

HERV-K and LINE-1 DNA methylation and reexpression in urothelial carcinoma
by: Ulrike eKreimer, et al.
Published: (2013-09-01)

DNA Methylation as a Therapeutic Target for Bladder Cancer
by: Sandra P. Nunes, et al.
Published: (2020-08-01)

Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma.
by: Roupret, M, et al.
Published: (2004)

New therapeutic targets in the management of urothelial carcinoma of the bladder
by: Sverrisson EF, et al.
Published: (2013-03-01)

Reply from Authors re: David J. DeGraff. Novel Use of a Combined Artificial Intelligence Approach to Identify Patients with Noninvasive Urothelial Cell Carcinoma of the Urinary Bladder Who Are at Greatest Risk for Progression to Muscle-Invasive Disease: A Step Forward. Eur Urol 2010; 57: 407-8
by: Catto, J, et al.
Published: (2010)

A gene promoter hypermethylation panel to detect transitional cell carcinoma of the bladder
by: Yates, DR, et al.
Published: (2006)

Genetic instability and transitional cell carcinoma of the bladder.
by: Catto, J, et al.
Published: (2004)

Compared performance of microsatellite and methylation urinalysis in predicting recurrence in transitional cell carcinoma and definition of a diagnostic panel of markers by bayesian network analysis
by: Roupret, M, et al.
Published: (2007)

S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors.
by: Rehman, I, et al.
Published: (2004)

HUS1 as a Potential Therapeutic Target in Urothelial Cancer
by: Andrea Katharina Lindner, et al.
Published: (2022-04-01)

Multiparametric Classification of Non-Muscle Invasive Papillary Urothelial Neoplasms: Combining Morphological, Phenotypical, and Molecular Features for Improved Risk Stratification
by: Ivonne A. Montes-Mojarro, et al.
Published: (2022-07-01)

Proteomic analysis of voided urine following prostatic massage reveals tumour specific alterations
by: Rehman, I, et al.
Published: (2004)

Cutaneous invasion from sarcomatoid urothelial carcinoma: clinical and dermatopathologic features
by: Fred Bernardes Filho, et al.
Published: (2016-02-01)

Stem cell phenotype predicts therapeutic response in glioblastomas with MGMT promoter methylation
by: Nelli S. Lakis, et al.
Published: (2022-11-01)